Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis

ABSTRACT Objective The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients’ satisfaction with the treatment must be taken into consideration. Methods Ind...

Full description

Bibliographic Details
Main Authors: Caroline Vieira Spessotto, Hanaie Cavalli, Audred Cristina Biondo Eboni, Rafael Berlezi Machado, Analara Munardi Mousquer, Lara Both Palazzo, Alessandro Finkelsztejn, Marcus Vinicius Magno Goncalves, Henry Koiti Sato, Fabio Siquineli, Yara Dadalti Fragoso
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2016-08-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
esclerose múltipla
acetato de glatiramer
interferon beta
natalizumab
cloridrato de fingolimode
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016000800617&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2016000800617&lng=en&tlng=en

Similar Items